annual cash & cash equivalents:
$3.30B+$74.00M(+2.29%)Summary
- As of today (September 18, 2025), TEVA annual cash & cash equivalents is $3.30 billion, with the most recent change of +$74.00 million (+2.29%) on December 31, 2024.
- During the last 3 years, TEVA annual cash & cash equivalents has risen by +$1.14 billion (+52.42%).
- TEVA annual cash & cash equivalents is now -52.49% below its all-time high of $6.95 billion, reached on December 31, 2015.
Performance
TEVA Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$2.16B+$464.03M(+27.34%)Summary
- As of today (September 18, 2025), TEVA quarterly cash & cash equivalents is $2.16 billion, with the most recent change of +$464.03 million (+27.34%) on June 30, 2025.
- Over the past year, TEVA quarterly cash & cash equivalents has dropped by -$96.97 million (-4.29%).
- TEVA quarterly cash & cash equivalents is now -34.89% below its all-time high of $3.32 billion, reached on September 30, 2024.
Performance
TEVA quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TEVA Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.3% | -4.3% |
| 3 y3 years | +52.4% | +5.0% |
| 5 y5 years | +67.1% | -10.0% |
TEVA Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +52.4% | -34.9% | +27.3% |
| 5 y | 5-year | at high | +67.1% | -34.9% | +27.3% |
| alltime | all time | -52.5% | >+9999.0% | -34.9% | >+9999.0% |
TEVA Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $2.16B(+27.3%) |
| Mar 2025 | - | $1.70B(-48.6%) |
| Dec 2024 | $3.30B(+2.3%) | $3.30B(-0.6%) |
| Sep 2024 | - | $3.32B(+47.0%) |
| Jun 2024 | - | $2.26B(-24.5%) |
| Mar 2024 | - | $2.99B(-7.3%) |
| Dec 2023 | $3.23B(+15.2%) | $3.23B(+43.4%) |
| Sep 2023 | - | $2.25B(-15.7%) |
| Jun 2023 | - | $2.67B(+24.5%) |
| Mar 2023 | - | $2.14B(-23.5%) |
| Dec 2022 | $2.80B(+29.4%) | $2.80B(+25.9%) |
| Sep 2022 | - | $2.23B(+8.1%) |
| Jun 2022 | - | $2.06B(-5.4%) |
| Mar 2022 | - | $2.17B(+0.5%) |
| Dec 2021 | $2.17B(-0.6%) | $2.17B(+5.9%) |
| Sep 2021 | - | $2.04B(-16.1%) |
| Jun 2021 | - | $2.44B(+39.8%) |
| Mar 2021 | - | $1.74B(-19.9%) |
| Dec 2020 | $2.18B(+10.2%) | $2.18B(+19.2%) |
| Sep 2020 | - | $1.83B(-23.9%) |
| Jun 2020 | - | $2.40B(+33.1%) |
| Mar 2020 | - | $1.80B |
| Dec 2019 | $1.98B(+10.8%) | - |
| Dec 2018 | $1.78B(+85.0%) | - |
| Dec 2017 | $963.00M(-2.5%) | - |
| Dec 2016 | $988.00M(-85.8%) | - |
| Dec 2015 | $6.95B(+212.0%) | - |
| Dec 2014 | $2.23B(+114.5%) | - |
| Dec 2013 | $1.04B(-63.9%) | - |
| Dec 2012 | $2.88B(+162.7%) | - |
| Dec 2011 | $1.10B(-12.2%) | - |
| Dec 2010 | $1.25B(-37.4%) | - |
| Dec 2009 | $2.00B(+7.6%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2008 | $1.85B(+24.6%) | - |
| Dec 2007 | $1.49B(+11.7%) | - |
| Dec 2006 | $1.33B(+4.4%) | - |
| Dec 2005 | $1.28B(+62.8%) | - |
| Dec 2004 | $784.00M(-25.8%) | - |
| Dec 2003 | $1.06B(+30.5%) | - |
| Dec 2002 | $809.90M(+5.3%) | - |
| Jun 2002 | - | $577.61M(-11.7%) |
| Mar 2002 | - | $653.80M(-15.0%) |
| Dec 2001 | $768.92M(+82.8%) | $768.92M(-4.3%) |
| Sep 2001 | - | $803.30M(+139.0%) |
| Jun 2001 | - | $336.09M(-4.8%) |
| Mar 2001 | - | $353.06M(-16.1%) |
| Dec 2000 | $420.63M(+445.0%) | $420.63M(+350.3%) |
| Jun 2000 | - | $93.41M(-13.7%) |
| Mar 2000 | - | $108.25M(+94.0%) |
| Dec 1999 | $77.18M(+63.9%) | - |
| Dec 1998 | $47.10M(-7.5%) | - |
| Sep 1998 | - | $55.80M(-41.4%) |
| Jun 1998 | - | $95.30M(+56.5%) |
| Mar 1998 | - | $60.90M(+19.6%) |
| Dec 1997 | $50.90M(-16.8%) | $50.90M(-16.8%) |
| Dec 1996 | $61.20M(-5.7%) | $61.20M(-5.7%) |
| Dec 1995 | $64.90M(+53.1%) | $64.90M(+53.1%) |
| Dec 1994 | $42.40M(+6.3%) | $42.40M(+6.3%) |
| Dec 1993 | $39.90M(+189.1%) | $39.90M(+189.1%) |
| Dec 1992 | $13.80M(+74.7%) | $13.80M(+74.7%) |
| Dec 1991 | $7.90M(-48.7%) | $7.90M(-48.7%) |
| Dec 1990 | $15.40M(+234.8%) | $15.40M(+234.8%) |
| Dec 1989 | $4.60M(-64.9%) | $4.60M(-64.9%) |
| Dec 1988 | $13.10M(-17.6%) | $13.10M(-17.6%) |
| Mar 1987 | $15.90M(-29.0%) | $15.90M(-29.0%) |
| Mar 1986 | $22.40M | $22.40M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual cash & cash equivalents year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly cash & cash equivalents year-on-year change?
What is Teva Pharmaceutical Industries Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of TEVA is $3.30B
What is the all time high annual cash & cash equivalents for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual cash & cash equivalents is $6.95B
What is Teva Pharmaceutical Industries Limited annual cash & cash equivalents year-on-year change?
Over the past year, TEVA annual cash & cash equivalents has changed by +$74.00M (+2.29%)
What is Teva Pharmaceutical Industries Limited quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of TEVA is $2.16B
What is the all time high quarterly cash & cash equivalents for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly cash & cash equivalents is $3.32B
What is Teva Pharmaceutical Industries Limited quarterly cash & cash equivalents year-on-year change?
Over the past year, TEVA quarterly cash & cash equivalents has changed by -$96.97M (-4.29%)